EDGAR Filing Documents for 0001553878-13-000001

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001553878-13-000001

Filing Date

2013-02-12

Accepted

2013-02-12 17:44:56

Documents

Period of Report

2013-02-08

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	primary_doc.html	4
1	PRIMARY DOCUMENT	primary_doc.xml	4	8148
	Complete submission text file	0001553878-13-000001.txt		9527

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142

Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200

ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142

Business Address

Type: 4 | Act: 34 | File No.: 000-50743 | Film No.: 13598582